Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cytek Biosciences Inc (CTKB)

Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Why Shares of Cytek Biosciences Dropped This Week

Cytek grew revenue and losses in the first quarter.

CTKB : 5.39 (-2.71%)
Cytek Biosciences Set to Join S&P SmallCap 600

/PRNewswire/ -- Cytek Biosciences Inc (NASD:CTKB) will replace Cardiovascular Systems Inc. (NASD:CSII) in the S&P SmallCap 600 effective prior to the opening...

SPGI : 512.22 (-0.85%)
CTKB : 5.39 (-2.71%)
CSII : 20.00 (+0.15%)
ABT : 113.56 (-0.39%)
Cytek Biosciences Reports Second Quarter 2022 Financial Results

Second quarter revenue grew 32% compared to prior year...

CTKB : 5.39 (-2.71%)
Cytek to Participate in the 42nd Annual Canaccord Genuity Global Growth Conference

FREMONT, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced the company...

CTKB : 5.39 (-2.71%)
Cytek Biosciences to Report Second Quarter 2022 Financial Results on August 10, 2022

FREMONT, Calif., July 20, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will...

CTKB : 5.39 (-2.71%)
Kunlun Capital Helps Medical Companies Grow in the Long Run

/PRNewswire/ -- Recently, Yahui Zhou, the founding partner of Kunlun Capital, won the 36kr 2022 " China 100 Best Investors Voted by Entrepreneurs " award and...

CTKB : 5.39 (-2.71%)
Cytek Biosciences to Host Inaugural Analyst and Investor Day

FREMONT, Calif., June 01, 2022 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB) announced today that it will...

CTKB : 5.39 (-2.71%)
Cytek® Biosciences Receives CE Marking for Series of cFluor® Reagents, TBNK Kit

Company Moves to Make Total Cell Analysis Solutions Available for Clinical Applications in the European Market...

CTKB : 5.39 (-2.71%)
Cytek Biosciences Reports First Quarter 2022 Financial Results

First quarter revenue grew 44% compared to prior year...

CTKB : 5.39 (-2.71%)
Cytek Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results

2021 Revenue Increased 38% Compared to Prior Year FREMONT, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or...

CTKB : 5.39 (-2.71%)

Barchart Exclusives

S&P Futures Slip as Middle East Crisis Weighs on Sentiment, U.S. ADP Jobs Report in Focus
December S&P 500 E-Mini futures (ESZ24) are trending down -0.37% this morning as flaring tensions in the Middle East dampened sentiment, while investors braced for the ADP National Employment numbers due later in the day. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar